Optinose shares plunge on pricing of $35M stock offering
August 17, 2020 at 06:30 AM EDT
Part of the money will be used for the clinical development of a Covid-19 therapeutic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|